Impact of short-term antiretroviral therapy (START) on some fibrinolytic markers in HIV-infected Nigerian adults: preliminary findings from the START study

Zaccheaus A Jeremiah1 Hematology and Blood Transfusion Science Unit, Department of Medical Laboratory Sciences, College of Health Sciences, Niger Delta University, Wilberforce Island, Bayelsa StateCorrespondence[email protected]

Yetunde Obazee2 General Hospital, Maitama District, Abuja, Federal Capital Territory

Godwin R Okogun3 Department of Medical Laboratory Science, Ambrose Ali University, Ekpoma, Edo State, Nigeria

Teddy C Adias4 College of Health Technology, Bayelsa State, Nigeria

Osaro Mgbere5 Houston Department of Health and Human Services, University of Houston, Texas Medical Center, Houston, TX, USA;6 Institute of Community Health, University of Houston, Texas Medical Center, Houston, TX, USA

Ekere J Essien6 Institute of Community Health, University of Houston, Texas Medical Center, Houston, TX, USA

Pages 87-94 | Published online: 10 Jul 2012

Cite this article

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

MurphyELCollierACKalishLAHighly active anti-retroviral therapy decreases mortality and morbidity in patients with advanced HIV diseaseAnn Intern Med20011351172611434728
PubMed Web of Science ®Google Scholar
PassalarisJDSepkowitzKAGlesbyMJCoronary artery disease and human immunodeficiency virus infectionClin Infect Dis200031378779711017831
PubMed Web of Science ®Google Scholar
RhewDCBernalMAguilarDIloejeUGoetzMBAssociation between protease inhibitor rise and increased cardiovascular risk in patients infected with human immunodeficiency virus: a systematic reviewClin Infect Dis200337795997213130409
PubMed Web of Science ®Google Scholar
GorogDAPrognostic value of plasma fibrinolysis activation markers in cardiovascular diseasesJ Am Coll Cardiol201055242701270920538163
PubMed Web of Science ®Google Scholar
NordenhamAWimanBTissue plasminogen activator (tPA) antigen in plasma: correlation with different tPA/inhibitor complexesScand J Clin Lab Invest19985864754839832339
PubMed Web of Science ®Google Scholar
WimanBPredictive value of fibrinolytic factors in coronary heart diseaseScand J Clin Lab Invest Suppl1999230233110389198
PubMedGoogle Scholar
MayMLawlorDAPatelRRumleyALoweGEbrahimSAssociation of von Willebrand factor, fibrin D-dimer and tissue plasminogen activator with incident coronary heart disease: British Women’s Heart and Health cohort studyEur J Cardiovasc Prev Rehabil200714563864517925622
PubMedGoogle Scholar
CrumNFRiffenburghRHWegnerSComparison of causes of death and mortality rates among HIV-infected persons: analysis of pre-, early, and late HAART (highly active antiretroviral therapy) erasJ Aquire Immune Defic Syndr2006412194200
PubMed Web of Science ®Google Scholar
ValdezHConnickESmithKYLimited immune restoration after 3 years’ suppression of HIV-1 replication in patients with moderately advanced diseaseAIDS200216141859186612351945
PubMed Web of Science ®Google Scholar
RossRAtherosclerosis – an inflammatory diseaseN Engl J Med199934021151269887164
PubMed Web of Science ®Google Scholar
HanssonCKLibbyPSchönbeckUYanZQInnate and adaptive immunity in the pathogenesis of atherosclerosisCirc Res200291428129112193460
PubMed Web of Science ®Google Scholar
NguemaimNFMbuagbawJNkoaTChanges in lipid profiles in two groups of HIV-1 infected patients in Cameroon on two treatment regimens with either Efavirenz or Nevirapine, in association with reverse transcriptase inhibitorsJ Med Sci20101022533
Google Scholar
NguemainNFMbuagbawJNkoaTSerum lipid profile in highly active antiretroviral therapy-naïve-HIV infected patients in Cameroon: a case-control studyHIV Med201011635335920345886
PubMed Web of Science ®Google Scholar
BeerasconiEUhrMMagentaLRannoATelentiASwiss HIV Cohort StudyHomocysteinaemia in HIV-infected patients treated with highly active antiretroviral therapyAIDS20011581081108211400001
PubMed Web of Science ®Google Scholar
KoppelKBrattGSchulmanSBylundHSandströmEHypofibrinolytic state in HIV infected patients treated with protease inhibitor-containing highly active antiretroviral therapyJ Aquir Immune Defic Syndr2002295441449
PubMed Web of Science ®Google Scholar
FolsomARFibrinolytic factors and atherothrombotic events: epidemiological evidenceAnn Med200032 Suppl 1859111209988
PubMed Web of Science ®Google Scholar
GeorgeSLSwindellsSKnudsonRStapletonJTUnexplained thrombosis in HIV-infected patients receiving protease inhibitors: report of seven casesAm J Med1999107662463010625032
PubMed Web of Science ®Google Scholar
JacobsonMCDezubeBJAboulafiaDMThrombotic complications in patients infected with HIV in the era of highly active antiretroviral therapy: a case seriesClin Infect Dis20043981214122215486847
PubMed Web of Science ®Google Scholar
Crum-CianfloneNFWeekesJBavaroMReview: thromboses among HIV-infected patients during the highly active antiretroviral therapy eraAIDS Patient Care STDS2008221077177818783326
PubMed Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Impact of short-term antiretroviral therapy (START) on some fibrinolytic markers in HIV-infected Nigerian adults: preliminary findings from the START study

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Impact of short-term antiretroviral therapy (START) on some fibrinolytic markers in HIV-infected Nigerian adults: preliminary findings from the START study

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date